XML 45 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Incentive Plans
3 Months Ended
Mar. 31, 2013
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 6 – Equity Incentive Plans

 

General

 

DCT’s share-based awards are long-term retention plans that are intended to attract, retain and provide incentives for talented employees. DCT believes its share-based awards are critical to its operation and productivity. The employee share-based award plans allow DCT to grant, on a discretionary basis, incentive stock options and non-qualified stock options.

 

The following table sets forth, by the respective option plan, certain aspects of DCT’s stock options as of March 31, 2013:

 

    Option Approval Method     Options Outstanding and Options Available  
Description   Board of
Directors
    Board of
Directors
and
Shareholders
    Total     Outstanding     Available
For
Future
Grant
    Total  
2002 Amended and Restated Stock Option Plan           3,200,000       3,200,000       3,200,000             3,200,000  
2006 Stock Option Plan           2,500,000       2,500,000       2,500,000             2,500,000  
2009 Stock Option Plan           1,500,000       1,500,000       1,500,000             1,500,000  
2010 Stock Option Plan           3,500,000       3,500,000       3,500,000             3,500,000  
2013 Stock Option Plan     3,500,000             3,500,000       1,245,043       2,254,957       3,500,000  
Key Personnel Option Grants     5,075,000             5,075,000       4,518,465             4,518,465  
      8,575,000       10,700,000       19,275,000       16,463,508       2,254,957       18,718,465  

 

Stock Options

 

DCT issues options under five different stock option plans as well as through employment agreements with key employees, executives and consultants (approved by the board of directors on a case-by-case basis).  Options generally vest over two to three years from the date of grant and expire seven to ten years from the date of grant.

 

Stock-Based Compensation

 

The following table sets forth the total stock-based compensation expense included in DCT’s Statements of Operations (in thousands):

 

    Three Months Ended March
 31,
 
    2013     2012  
Selling, general and administrative   $ 171     $ 233  
Research and development     5       14  
    $ 176     $ 247  

 

At March 31, 2013, DCT had approximately $586,000 of total unrecognized compensation cost related to unvested stock options. This cost is expected to be recognized over a weighted-average period of approximately 1.85 years.

 

Stock Option Activity and Outstanding

 

DCT had the following stock option activity during the three months ended March 31, 2013:

 

    Options     Weighted-
Average
Exercise
Price
 
Outstanding at December 31, 2012     13,100,508     $ 0.38  
Granted     3,813,000       0.16  
Cancelled     450,000       0.37  
Outstanding at March 31, 2013     16,463,508     $ 0.33  
Vested or expected to vest at March 31, 2013     16,463,508     $ 0.33  

 

In January 2013, as part of the 2013 Restructure, DCT’s Board of Directors approved a nine-month extension to 1,583,333 options that were scheduled to expire in April 2013.  The total fair value of the amended options, as calculated using the Black-Scholes valuation model, was approximately $80,000 and was recorded as operating expense with the offsetting credit to additional paid-in capital during the three months ended March 31, 2013.

 

In March 2013, DCT’s Board of Director’s approved a one-year extension to 300,000 options that were scheduled to expire April 2013. The total fair value of the amended options, as calculated using the Black-Scholes valuation model, was approximately $1,000 and was recorded as operating expense with the offsetting credit to additional paid-in capital during the three months ended March 31, 2013.

 

The following table summarizes all options outstanding and exercisable by price range as of March 31, 2013:

 

    Options Outstanding     Options Exercisable  
Range of
Exercise Prices
  Number
Outstanding
    Weighted-
Average
Remaining
Contractual
Life (Years)
    Weighted-
Average
Exercise
Price
    Number
Exercisable
    Weighted-
Average
Exercise
Price
 
$0.01     643,465       0.5     $ 0.01       643,465     $ 0.01  
$0.12-$0.17     3,813,000       9.8     $ 0.16              
$0.29-$0.45     9,107,043       4.2     $ 0.31       8,538,288     $ 0.31  
$0.60-$0.70     2,900,000       5.2     $ 0.68       2,900,000     $ 0.68  
      16,463,508                       12,081,753          

 

The “intrinsic value” of options is the excess of the value of DCT stock over the exercise price of such options. The total intrinsic value of options outstanding (of which all are expected to vest) at March 31, 2013 was approximately $96,000. The total intrinsic value of options outstanding at December 31, 2012 was $103,000. The total intrinsic value for exercisable options was $84,000 and $103,000 at March 31, 2013 and December 31, 2012, respectively. No options were exercised during the three months ended March 31, 2013. The total intrinsic value was $27,000 for options exercised during the three months ended March 31, 2012.